Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.

ABSTRACT: Hematopoietic stem cell transplantation (HCT) is a curative treatment option for patients with hematologic conditions but presents many complications that must be managed as a complex, chronic condition. Mobile health applications (mHealth apps) may permit tracking of symptoms in HCT. In seeking strategies to manage the complexities of HCT, our team collaborated with Sicklesoft, Inc., to develop an mHealth app specifically for HCT patients to allow for daily evaluation of patient health, Technology Recordings to better Understand Bone Marrow Transplantation (TRU-BMT). The primary value of this application is that of potentially enhancing the monitoring of symptoms and general health of patients undergoing HCT, with the ultimate goal of allowing earlier detection of adverse events, earlier

SUBMITTER: Racioppi A 

PROVIDER: S-EPMC10522407 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature